Citigroup Lowers PT on Human Genome Sciences to $8

Symbols: HGSI
Tags: Citigroup
Share

Citigroup has lowered the price target on Human Genome Sciences (NASDAQ: HGSI) from $12 to $8 and maintains its Neutral rating.


 
 
< Previous
Societe Generale Downgrades Oracle to Hold
Next >
Barrington Initiates RealPage at Outperform
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust